These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2405921)

  • 21. A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers.
    van Pelt LJ; Huisman MV; Weening RS; von dem Borne AE; Roos D; van Oers RH
    Blood; 1996 Jun; 87(12):5305-13. PubMed ID: 8652846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.
    Wing EJ; Magee DM; Whiteside TL; Kaplan SS; Shadduck RK
    Blood; 1989 Feb; 73(3):643-6. PubMed ID: 2465038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes.
    Elliott MJ; Vadas MA; Eglinton JM; Park LS; To LB; Cleland LG; Clark SC; Lopez AF
    Blood; 1989 Nov; 74(7):2349-59. PubMed ID: 2553163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of interleukin 1, macrophage colony-stimulating factor, and factor increasing monocytopoiesis on the production of leukocytes in mice.
    Annema A; Sluiter W; van Furth R
    Exp Hematol; 1992 Jan; 20(1):69-74. PubMed ID: 1577096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and subacute hematologic effects of multi-colony stimulating factor in combination with granulocyte colony-stimulating factor in vivo.
    Ulich TR; del Castillo J; McNiece IK; Yin SM; Irwin B; Busser K; Guo KZ
    Blood; 1990 Jan; 75(1):48-53. PubMed ID: 1688501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of monocyte migration by recombinant macrophage colony-stimulating factor.
    Wang JM; Griffin JD; Rambaldi A; Chen ZG; Mantovani A
    J Immunol; 1988 Jul; 141(2):575-9. PubMed ID: 3290341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes.
    Lindemann A; Riedel D; Oster W; Ziegler-Heitbrock HW; Mertelsmann R; Herrmann F
    J Clin Invest; 1989 Apr; 83(4):1308-12. PubMed ID: 2467922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte/macrophage colony-stimulating factor stimulates monocyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony-stimulating factor.
    Chen BD; Clark CR; Chou TH
    Blood; 1988 Apr; 71(4):997-1002. PubMed ID: 2833334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colony-stimulating factors and interferon-gamma differentially affect cell surface molecules shared by monocytes and neutrophils.
    Buckle AM; Jayaram Y; Hogg N
    Clin Exp Immunol; 1990 Aug; 81(2):339-45. PubMed ID: 2117512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of recombinant human granulocyte-colony stimulating factor after intravenous and subcutaneous administration in the rat.
    Tanaka H; Okada Y; Kawagishi M; Tokiwa T
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1199-203. PubMed ID: 2481032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
    Young DA; Lowe LD; Clark SC
    J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor in rhesus monkeys.
    Mayer P; Lam C; Obenaus H; Liehl E; Besemer J
    Ann N Y Acad Sci; 1987; 511():17-29. PubMed ID: 2830822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell factor in combination with granulocyte colony-stimulating factor (CSF) or granulocyte-macrophage CSF synergistically increases granulopoiesis in vivo.
    Ulich TR; del Castillo J; McNiece IK; Yi ES; Alzona CP; Yin SM; Zsebo KM
    Blood; 1991 Oct; 78(8):1954-62. PubMed ID: 1717076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture.
    Coutinho LH; Will A; Radford J; Schiró R; Testa NG; Dexter TM
    Blood; 1990 Jun; 75(11):2118-29. PubMed ID: 1693295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    Sampson-Johannes A; Carlino JA
    J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematologic interactions of endotoxin, tumor necrosis factor alpha (TNF alpha), interleukin 1, and adrenal hormones and the hematologic effects of TNF alpha in Corynebacterium parvum-primed rats.
    Ulich TR; del Castillo J; Ni RX; Bikhazi N
    J Leukoc Biol; 1989 Jun; 45(6):546-57. PubMed ID: 2786048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematologic effects of stem cell factor alone and in combination with G-CSF and GM-CSF in vivo and in vitro in rodents.
    Ulich TR; Yi ES; Yin S; del Castillo J; McNiece I; Yung YP; Zsebo KM
    Int Rev Exp Pathol; 1993; 34 Pt A():215-33. PubMed ID: 7681048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.